Press What’s news at AbelsonTaylor Group
Select category
An Indie POV on the Omnicom-Interpublic Merger
AT Group President Jeff Berg recently joined MM+M’s Jack O’Brien to discuss the future of the medical advertising industry in...
Read more An Indie POV on the Omnicom-Interpublic MergerHow will pharma marketers crack the AI code in 2025?
MM+M January 3, 2025 In the article, “How will pharma marketers crack the AI code in 2025?” AbelsonTaylor Group’s Amy...
Top Innovations of 2024: AT Activate
Established in 2012, PM360 introduced the first-ever issue focused entirely on the pharma and healthcare marketing industry’s latest innovations. In 2024,...
Five Data-Driven Media Planning Principles for Pharma Marketers in 2025
Data-driven media planning is not just about crunching numbers—it’s about understanding people. Account Planning and Insight Innovation VP Mike Czuba...
4 Magic Consumer Campaigns That Could Inspire Pharma
AbelsonTaylor Group’s VP Creative Director Richard How explores several health-related consumer campaigns and the potential impact they could have on...
Top Biopharma/Biotech Trends to Watch in 2025
Offering views on top trends to watch, Eric Densmore, SVP, Director of Business Development, and Lane Degenhart VP Account Director,...
Building an Environment of Diversity, Equity, Inclusion, and Belonging
Senior Vice President of People Experience, Beth Bogacz, shares her thoughts on how AT Group’s culture of psychological safety contributes...
Commitment to Flexibility, Partnership, and Human Connection Fosters Stronger Outcomes
As part of the annual MedAdNews Healthcare Agency Roundtable discussion, AbelsonTaylor Group’s Christe Volke, VP of Media Strategy, offers her insights...
From Tik Tok to Digital Opinion Leaders, Social Media’s Integral Role in Strategy and Engagement
In the MedAdNews annual Healthcare Agency Roundtable, AbelsonTaylor Group experts weigh in on social media’s role in strategy and engagement....
Tech to Fuel Better Connectivity with HCPs, Patients, and Caregivers
AbelsonTaylor Group’s Christe Volke, VP, Media Strategy, discusses which technologies are facilitating better targeting of audiences to drive more personalized,...
Moving Into 2024
Applying his background in pharmacology, Jeff Berg, President of AbelsonTaylor Group, discusses a particularly exciting use of AI in drug discovery that...
Jody Van Swearingen Talks to Marketing & Pharma About Color in Pharma Brands
AT Group’s Jody Van Swearingen, SVP – Creative Director, talks to Marketing & Pharma about the detailed and thoughtful and...
